title: Can febuxostat reduce triglyceride and cholesterol serum levels in gouty patients?
authors.affiliation: Rheumatology and Rehabilitation Unit Salvatore Maugeri Foundation IRCCS Mantua gianantonio.saviola@fsm.it Rheumatology Unit Department of Internal Medicine Hospital S. Giovanni di Dio Florence Rheumatology and Rehabilitation Unit Salvatore Maugeri Foundation IRCCS Mantua Laboratory and Clinical Biochemistry Unit Salvatore Maugeri Foundation IRCCS Mantua Rheumatology and Rehabilitation Unit Salvatore Maugeri Foundation IRCCS Mantua Rheumatology Unit Department of Medicine University of Verona Verona, Italy.
authors.forename: Gianantonio
authors.initials: G
authors.lastname: Saviola
authors.forename: Maurizio
authors.initials: M
authors.lastname: Benucci
authors.forename: Lul
authors.initials: L
authors.lastname: Abdi-Ali
authors.forename: Silvano
authors.initials: S
authors.lastname: Sacco
authors.forename: Ilaria
authors.initials: I
authors.lastname: Cera
authors.forename: Maurizio
authors.initials: M
authors.lastname: Rossini
mesh_terms: D000368:Aged; D002784:Cholesterol / Q000097:blood*; D000069465:Febuxostat; D005260:Female; D006073:Gout / Q000097:blood* / Q000188:drug therapy*; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013844:Thiazoles / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood*
chemical_list: D006074:Gout Suppressants; D013844:Thiazoles; D014280:Triglycerides; D000069465:Febuxostat; D002784:Cholesterol